Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs
(1) Background: Policies and laws in several jurisdictions across the globe have aimed to promote harm minimisation or reduction, through the implementation of Needle and Syringe Programs (NSP) for people who inject drugs (PWID), for whom abstinence may not be possible or desired. While NSPs hold gr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Series: | Healthcare |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9032/10/5/781 |
| _version_ | 1797499530923474944 |
|---|---|
| author | Danielle Resiak Elias Mpofu Roderick Rothwell |
| author_facet | Danielle Resiak Elias Mpofu Roderick Rothwell |
| author_sort | Danielle Resiak |
| collection | DOAJ |
| description | (1) Background: Policies and laws in several jurisdictions across the globe have aimed to promote harm minimisation or reduction, through the implementation of Needle and Syringe Programs (NSP) for people who inject drugs (PWID), for whom abstinence may not be possible or desired. While NSPs hold great promise, their implementation qualities are understudied. (2) Aim: We aimed to examine the implementation quality priorities of NSP providers and PWID consumers in an Australian setting. (3) Method: This study utilised a Quantitative-qualitative (QUAN-qual) mixed methods approach. Survey participants included both PWID (<i>n</i> = 70) and NSP providers (<i>n</i> = 26) in Australia. (4) Results: Results following non-parametric data analysis indicate NSP providers prioritised NSP implementation qualities in the following order: compatibility, observability, relative advantage, resourcing and trialability. Contrary to which, PWID prioritised resourcing, compatibility, relative advantage and trialability, respectively. Findings demonstrate that efficacy of implementation qualities is dependent on the juxtaposition of service provision and utilisation whereby implementation quality priorities are balanced. (5) Conclusions: This research presents novel findings guiding NSP harm reduction programmes for sustainability framed on provider and consumer implementation quality priorities. We envisage future studies on boundary conditions of NSP harm reduction implementation in other jurisdictions. |
| first_indexed | 2024-03-10T03:48:43Z |
| format | Article |
| id | doaj.art-d42a972b01c349fba93312185058949a |
| institution | Directory Open Access Journal |
| issn | 2227-9032 |
| language | English |
| last_indexed | 2024-03-10T03:48:43Z |
| publishDate | 2022-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Healthcare |
| spelling | doaj.art-d42a972b01c349fba93312185058949a2023-11-23T11:12:55ZengMDPI AGHealthcare2227-90322022-04-0110578110.3390/healthcare10050781Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject DrugsDanielle Resiak0Elias Mpofu1Roderick Rothwell2Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, Sydney, NSW 2006, AustraliaFaculty of Medicine and Health, School of Health Sciences, The University of Sydney, Sydney, NSW 2006, AustraliaFaculty of Medicine and Health, School of Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia(1) Background: Policies and laws in several jurisdictions across the globe have aimed to promote harm minimisation or reduction, through the implementation of Needle and Syringe Programs (NSP) for people who inject drugs (PWID), for whom abstinence may not be possible or desired. While NSPs hold great promise, their implementation qualities are understudied. (2) Aim: We aimed to examine the implementation quality priorities of NSP providers and PWID consumers in an Australian setting. (3) Method: This study utilised a Quantitative-qualitative (QUAN-qual) mixed methods approach. Survey participants included both PWID (<i>n</i> = 70) and NSP providers (<i>n</i> = 26) in Australia. (4) Results: Results following non-parametric data analysis indicate NSP providers prioritised NSP implementation qualities in the following order: compatibility, observability, relative advantage, resourcing and trialability. Contrary to which, PWID prioritised resourcing, compatibility, relative advantage and trialability, respectively. Findings demonstrate that efficacy of implementation qualities is dependent on the juxtaposition of service provision and utilisation whereby implementation quality priorities are balanced. (5) Conclusions: This research presents novel findings guiding NSP harm reduction programmes for sustainability framed on provider and consumer implementation quality priorities. We envisage future studies on boundary conditions of NSP harm reduction implementation in other jurisdictions.https://www.mdpi.com/2227-9032/10/5/781NSPNSP service providerPWIDimplementation qualitiescompatibilityobservability |
| spellingShingle | Danielle Resiak Elias Mpofu Roderick Rothwell Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs Healthcare NSP NSP service provider PWID implementation qualities compatibility observability |
| title | Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs |
| title_full | Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs |
| title_fullStr | Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs |
| title_full_unstemmed | Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs |
| title_short | Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs |
| title_sort | harm minimisation drug policy implementation qualities their efficacy with australian needle and syringe program providers and people who inject drugs |
| topic | NSP NSP service provider PWID implementation qualities compatibility observability |
| url | https://www.mdpi.com/2227-9032/10/5/781 |
| work_keys_str_mv | AT danielleresiak harmminimisationdrugpolicyimplementationqualitiestheirefficacywithaustralianneedleandsyringeprogramprovidersandpeoplewhoinjectdrugs AT eliasmpofu harmminimisationdrugpolicyimplementationqualitiestheirefficacywithaustralianneedleandsyringeprogramprovidersandpeoplewhoinjectdrugs AT roderickrothwell harmminimisationdrugpolicyimplementationqualitiestheirefficacywithaustralianneedleandsyringeprogramprovidersandpeoplewhoinjectdrugs |